Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.taap.2008.02.026
DC FieldValue
dc.titleIn vitro and in vivo evaluation of the effects of piperine on P-gp function and expression
dc.contributor.authorHan, Y.
dc.contributor.authorChin Tan, T.M.
dc.contributor.authorLim, L.-Y.
dc.date.accessioned2014-10-29T01:54:06Z
dc.date.available2014-10-29T01:54:06Z
dc.date.issued2008-08-01
dc.identifier.citationHan, Y., Chin Tan, T.M., Lim, L.-Y. (2008-08-01). In vitro and in vivo evaluation of the effects of piperine on P-gp function and expression. Toxicology and Applied Pharmacology 230 (3) : 283-289. ScholarBank@NUS Repository. https://doi.org/10.1016/j.taap.2008.02.026
dc.identifier.issn0041008X
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/106037
dc.description.abstractPiperine, a major component of black pepper, is used as spice and nutrient enhancer. The purpose of the present study was to evaluate the effects of acute and prolonged piperine exposure on cellular P-gp expression and function in vitro and in vivo. Piperine at concentrations ranging from 10 to 100 μM, determined by MTT assay to be non-cytotoxic, was observed to inhibit P-gp mediated efflux transport of [3H]-digoxin across L-MDR1 and Caco-2 cell monolayers. The acute inhibitory effect was dependent on piperine concentration, with abolishment of [3H]-digoxin polarized transport attained at 50 μM of piperine. In contrast, prolonged (48 and 72 h) co-incubation of Caco-2 cell monolayers with piperine (50 and 100 μM) increased P-gp activity through an up-regulation of cellular P-gp protein and MDR1 mRNA levels. The up-regulated protein was functionally active, as demonstrated by a higher degree of [3H]-digoxin efflux across the cell monolayers, but the induction was readily reversed by the removal of the spice from the culture medium. Peroral administration of piperine at the dose of 112 μg/kg body weight/day to male Wistar rats for 14 consecutive days also led to increased intestinal P-gp levels. However, there was a concomitant reduction in the rodent liver P-gp although the kidney P-gp level was unaffected. Our data suggest that caution should be exercised when piperine is to be co-administered with drugs that are P-gp substrates, particularly for patients whose diet relies heavily on pepper. © 2008 Elsevier Inc. All rights reserved.
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1016/j.taap.2008.02.026
dc.sourceScopus
dc.subjectDigoxin transport
dc.subjectMDR1
dc.subjectP-gp
dc.subjectPiperine
dc.typeArticle
dc.contributor.departmentPHARMACY
dc.description.doi10.1016/j.taap.2008.02.026
dc.description.sourcetitleToxicology and Applied Pharmacology
dc.description.volume230
dc.description.issue3
dc.description.page283-289
dc.description.codenTXAPA
dc.identifier.isiut000258412200003
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.